HFA Premium Access

Chronic Heart Failure - Pathophysiology and Mechanisms 1

Event: Heart Failure 2021 Online Congress
Topic: Pathophysiology and Mechanisms
Session type: Abstract Sessions
Date: 29 June 2021
Time: 14:00 - 15:00

Congress Session

10 presentations in this session

Real world analysis of outcomes of remote pulmonary artery hemodynamic monitoring in overweight and obese patients with heart failure

Speaker: Doctor M. Oberoi (Sioux Falls, US)

Multicenter nationwide study of the prevalence of ATTR-CM in HFpEF in Spain. Intermediate results from national PRACTICA study.

Speaker: Doctor J. Garcia-Pinilla (Malaga, ES)

HDAC6 inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction

Speaker: Mr J. Yang (South San Francisco, US)

Pulmonary hypertension in heart failure with preserved ejection fraction: the TOPCAT Americas and PARAGON-HF studies

Speaker: Doctor K. Jering (Boston, US)

Changes in natriuretic peptide and effects of vericiguat in worsening heart failure with reduced ejection fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF)

Speaker: Doctor J. Ezekowitz (Edmonton, CA)

Initiation of sacubitril/valsartan in patients with renal impairment early after acute decompensated heart failure in the TRANSITION study

Speaker: Professor E. Straburzynska-Migaj (Poznan, PL)

Impact of epicardial adipose tissue on cardiac hemodynamics and proteomics in heart failure with preserved ejection fraction: Insights from the PROMIS-HFpEF study

Speaker: Doctor A. Venkateshvaran (Stockholm, SE)

Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence

Speaker: Doctor O. Iborra Egea (Badalona, ES)

Significant association between left ventricular diastolic dysfunction, left atrial performance and liver stiffness in patients with metabolic syndrome and non-alcoholic fatty liver disease

Speaker: Mr T. Parvanescu (Timisoara, RO)

New advanced heart failure (HF) pig model with reduced ejection fraction and clinically relevant cardiopulmonary congestion.

Speaker: Doctor J. Melka (Suresnes, FR)

10 speakers from this session

Doctor Mansi Oberoi

Sanford Medical Center, Sioux Falls (United States of America)
0 follower

Doctor Jose Manuel Garcia-Pinilla

Hospital Universitario Virgen de la Victoria, Malaga (Spain)
0 follower

Mr Jin Yang

Tenaya Therapeutics, South San Francisco (United States of America)
0 follower

Doctor Karola Jering

Brigham and Women's Hospital, Boston (United States of America)
0 follower

Doctor Justin Ezekowitz

University of Alberta, Edmonton (Canada)
6 presentations
1 follower

Professor Ewa Straburzynska-Migaj

Poznan University of Medical Sciences, Poznan (Poland)
1 presentation
0 follower

Doctor Ashwin Venkateshvaran

Karolinska Institute, Stockholm (Sweden)
0 follower

Doctor Oriol Iborra Egea

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)
1 presentation
0 follower

Mr Tudor Parvanescu

ASCAR Cardiology Clinic, Timisoara (Romania)
0 follower

Doctor Jonathan Melka

Servier Research Institute, Suresnes (France)
0 follower

This platform is supported by

logo Novo Nordisk